BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 26, 2026
Home
»
Newsletters
» BioWorld
BioWorld
April 10, 2009
View Archived Issues
Cardiome Gets Much-Needed Deal in $800M Merck Alliance
Shares of Cardiome Pharma Corp. shot up 25 percent after it scored a crucial partnership for its late-stage atrial fibrillation drug, vernakalant. (BioWorld Today)
Read More
After PML Cases, Genentech Takes Raptiva off the Market
Read More
Mechanistics Guide Drug for Advanced Prostate Cancer
Read More
Celldex Dusting Off Program Idled Years Ago by Amgen
Read More
Clinic Roundup
Read More
Other News To Note
Read More
Financings Roundup
Read More
